Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:01052218n
Noun Concept
SYL
No term available
EN
Tezampanel is a drug originally developed by Eli Lilly which acts as a competitive antagonist of the AMPA and kainate subtypes of the ionotropic glutamate receptor family, with selectivity for the GluR5 subtype of the kainate receptor. Wikipedia
Relations
Sources
IS A
EN
carboxylic acid
EN
compound
PHYSICALLY INTERACTS WITH
EN
GRIA3
EN
GRIA1
EN
GRIA2
EN
GRIA4

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License